MedTrace Logo

An Observational Study of Blood Management Techniques in Oncology Surgical Treatment

NCT00264095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2014-04-28

No results posted yet for this study

Summary

The purpose of this study is to observe the methods used to manage blood loss in surgical procedures to remove tumors from patients with cancer and to determine if there is a relationship with the need for blood transfusions.

Conditions

  • Anemia
  • Blood Loss, Surgical
  • Neoplasms

Interventions

PROCEDURE

Oncological surgery

surgery is primary observed intervention and blood loss is between 500-3000 ml

Sponsors & Collaborators

  • Janssen-Cilag B.V.

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag B.V. Clinical Trial · Janssen-Cilag B.V.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00264095 on ClinicalTrials.gov